ESR1 and adrenal cortex carcinoma: Although expression of MYB-NFIB has been shown in triple-negative (ER, PR, HER2) breast ACC [5], immunohistochemistry showed a strong correlation between expression of ER and MYB in higher grade tumors from our mouse model.